Determination of risk and treatment of complications of prematurity

Details for Australian Patent Application No. 2002239560 (hide)

Owner ROP Pharma AB

Inventors Smith, Lois; Hellstrom, Ann

Agent Pizzeys

Pub. Number AU-B-2002239560

PCT Pub. Number WO02/43578

Priority 0004405 28.11.00 SE; 60274252 09.03.01 US

Filing date 13 November 2001

Wipo publication date 11 June 2002

Acceptance publication date 2 March 2006

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

26 June 2003 Amendment Made

  The nature of the amendment is: Amend the filing date of the priority document US 60274252 to 9 March 2001

13 January 2005 Amendment Made

  The nature of the amendment is: Add the co-applicant/patentee Ann Hellstrom 2003

2 March 2006 Application Accepted

  Published as AU-B-2002239560

9 March 2006 Assignment before Grant

  Children's Medical Center Corporation; Hellstrom, Ann The application has been assigned to ROP Pharma AB

29 June 2006 Standard Patent Sealed

17 January 2008 Assignment Registered

  ROP Pharma AB The patent has been assigned to Premacure AB

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002239561

2002239559-WAVEGUIDE OPTICAL FIBER FOR AMPLIFICATION WITHIN S-BAND OPTICAL RANGE